LESS THAN TWO MONTHS AFTER ANNOUNCING PLANS to sell off or otherwise divest of its in vitro diagnostics (IVD) and life sciences divisions, Becton Dickinson (BD) appears to be in talks already with several competitors about the would-be deal. Citing anonymous sources, the Financial Times reported on April 1 that BD had already engaged in […]
To access this post, you must purchase The Dark Report.